Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Approval
|
Falling Comet
1944.4000
3.90
(
0.20
%)
NSE
Oct 16, 2025
12:06 PM
Volume:
198.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
08 Aug 2024
US FDA Approval
1944.40
0.20%
Result Update:Lupin
Buy:
Lupin Ltd.
by
Axis Direct
Target: 2200
Target
Axis Direct
We have BUY on the Stock
Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
More from Lupin Ltd.
Recommended
Market trades higher, Oberoi Realty's Q2 revenue beats estimates by 31%
Trendlyne Marketwatch |
16 Oct 2025, 12:08PM
Rural India is spending more, but household incomes haven’t caught up
The Baseline |
15 Oct 2025, 01:21PM
Lupin expects normalization by September quarter
|
17 Apr 2020